Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CBOE GLOBAL MARKETS, INC.

(CBOE)
SummaryQuotesChartsNewsCalendarCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Cboe Global Markets : Bicycle Therapeutics Prices 4M ADS IPO @$14/ADS

05/22/2019 | 10:28pm EDT
Cboe - Market News Story
Bicycle Therapeutics Prices 4M ADS IPO @$14/ADS

Charles Gross 5/22/2019 8:50:46 PM

Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, today announced the pricing of its initial public offering in the United States of 4,333,333 American Depositary Shares ('ADSs') representing 4,333,333 ordinary shares at an initial public offering price of $14.00 per ADS, before underwriting discounts and commissions. In addition, Bicycle has granted the underwriters a 30-day option to purchase up to an additional 650,000 ADSs at the initial public offering price, less the underwriting discounts and commissions. Bicycle's ADSs are expected to begin trading on The Nasdaq Global Select Market on May 23, 2019 under the ticker symbol 'BCYC.' All of the ADSs are being offered by Bicycle. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Bicycle, are expected to be approximately $60.7 million, excluding any exercise of the underwriters' option to purchase additional ADSs. The offering is expected to close on May 28, 2019, subject to the satisfaction of customary closing conditions.

Goldman Sachs & Co. LLC, Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering. Canaccord Genuity LLC is acting as lead manager for the offering.



Disclaimer

CBOE Holdings Inc. published this content on 22 May 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 23 May 2019 02:27:02 UTC


© Publicnow 2019
All news about CBOE GLOBAL MARKETS, INC.
02/25CBOE GLOBAL MARKETS, INC. : Ex-dividend day for
FA
02/19CBOE GLOBAL MARKETS  : Management's Discussion and Analysis of Financial Conditi..
AQ
02/12CBOE GLOBAL MARKETS, INC.  : Change in Directors or Principal Officers, Financia..
AQ
02/05CBOE GLOBAL MARKETS  : 4Q Earnings Presentation
PU
02/05CBOE GLOBAL MARKETS  : Earning documents
PU
02/05CBOE : 4Q Earnings Snapshot
AQ
02/05CBOE GLOBAL MARKETS, INC.  : Results of Operations and Financial Condition, Fina..
AQ
2020CBOE GLOBAL MARKETS, INC.  : Entry into a Material Definitive Agreement, Creatio..
AQ
2020CBOE GLOBAL MARKETS, INC.  : Entry into a Material Definitive Agreement, Creatio..
AQ
2020CBOE GLOBAL MARKETS, INC.  : Other Events, Financial Statements and Exhibits (fo..
AQ
More news
Chart CBOE GLOBAL MARKETS, INC.
Duration : Period :
Cboe Global Markets, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
NameTitle
Edward Thomas Tilly Chairman, President & Chief Executive Officer
Brian N. Schell Chief Financial Officer, Treasurer & Executive VP
Eric Crampton Chief Technology Officer & Senior Vice President
Christopher A. Isaacson Chief Operating Officer & Executive VP
Janet P. Froetscher Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CBOE GLOBAL MARKETS, INC.5.98%12 893
HONG KONG EXCHANGES AND CLEARING LIMITED12.85%76 082
INTERCONTINENTAL EXCHANGE, INC.3.86%67 936
LONDON STOCK EXCHANGE PLC-14.52%59 098
DEUTSCHE BÖRSE AG6.03%32 448
NASDAQ, INC.19.50%26 274